Cargando…
Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review
Diffuse large B-cell lymphoma (DLBCL) is the most common histological subtype of non-Hodgkin’s lymphomas (NHL). DLBCL is an aggressive malignancy that displays a great heterogeneity in terms of morphology, genetics and biological behavior. While a sustained complete remission is obtained in the majo...
Autores principales: | Decruyenaere, Philippe, Offner, Fritz, Vandesompele, Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885416/ https://www.ncbi.nlm.nih.gov/pubmed/33593440 http://dx.doi.org/10.1186/s40164-021-00208-3 |
Ejemplares similares
-
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies
por: Decruyenaere, Philippe, et al.
Publicado: (2023) -
Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance
por: Drandi, Daniela, et al.
Publicado: (2022) -
Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review
por: Lopez-Santillan, Maria, et al.
Publicado: (2018) -
Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B‐cell lymphoma
por: Cao, Di, et al.
Publicado: (2021) -
Proteomics Identifies Circulating TIMP-1 as a Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
por: Lou, Ning, et al.
Publicado: (2023)